Cargando…
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products
Severe acute respiratory syndrome coronavirus 2 infected patients, receiving background anti-CD20 therapy, were treated with convalescent plasma or plasma-based products. Eight patients were included in the study, presenting with prolonged disease course and delayed viral clearance. CP/plasma-based...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024218/ https://www.ncbi.nlm.nih.gov/pubmed/33838340 http://dx.doi.org/10.1016/j.clim.2021.108723 |